BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: de Mattos AZ, Bombassaro IZ, Vogel A, Debes JD. Hepatocellular carcinoma-the role of the underlying liver disease in clinical practice. World J Gastroenterol 2024; 30(19): 2488-2495 [PMID: 38817660 DOI: 10.3748/wjg.v30.i19.2488]
URL: https://www.wjgnet.com/1948-5182/full/v30/i19/2488.htm
Number Citing Articles
1
Jian-Gao Fan, Rui-Nan Zhang. Lipid metabolism-related long noncoding RNAs: A potential prognostic biomarker for hepatocellular carcinomaWorld Journal of Gastroenterology 2024; 30(33): 3799-3802 doi: 10.3748/wjg.v30.i33.3799
2
Jhon E. Prieto, Diego R. Puentes, Angelo Z. Mattos, Enrique Carrera E., Javier Diaz Ferrer, Martín Padilla-Machaca, Domingo Balderramo, Manuel Mendizabal, Marco Arrese, Robin G. Prieto, Diana Torres, Marlon R. Toazza, Guilherme John Neto, Angelo A. Mattos, Cristina N. Zambrano R., Maria Grazia Venturelli Romero, Fortunato S. Principe-Meneses, Chiara Zecchin, Martin Salvatierra, Juan D. Córdoba, Daniela Moreno, Javier Eslava-Schmalbach, José D. Debes. Clinical, etiological, and demographic aspects of cirrhosis in South America: a report from the South American Liver Research NetworkAnnals of Hepatology 2026; 31(2) doi: 10.1016/j.aohep.2026.102186
3
Feng Gao, Xuefei Feng, Xinyu Li. Recent advances in polymeric nanoparticles for the treatment of hepatic diseasesFrontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1528752
4
Zhouxia Wei, Yingxian Li, Suyan Jiang. Evaluation of the efficacy of laparoscopic hepatolobectomy for primary liver cancer with early combined enteral and parenteral nutritional supportDiscover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02851-2
5
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
6
Tanya Saxena, Gabriela Guedes, Inês Domingues, Hafsa Yagoubi, Léo Guilbaud, William Van den Bossche, Cristina Pangua, Greetje Vande Velde, Bernard Ucakar, Andrea García-Esnaola, Isabelle Leclercq, Aitziber L. Cortajarena, Ana Beloqui. Engineered protein nanoclusters reduce liver fibrosis and hepatocellular carcinoma in mice modelsBioactive Materials 2026; 65 doi: 10.1016/j.bioactmat.2026.05.038
7
Soykan Agar. De novo Drug Design and Repurposing to Suppress Liver Cancer via VEGF-R1 Mechanism: Comprehensive Molecular Docking, Molecular Dynamics Simulations and ADME EstimationMedicinal Chemistry 2025; 21(6) doi: 10.2174/0115734064333811240928105309
8
Lei Yu, Cai-Yun Zhang, Xiao-Po Zhang, Hui Liao, Cang-Long Wei, Cai-Yan Pan, Zheng-Wen Wang. Oxocrebanine inhibits the proliferation of hepatocellular carcinoma cells by promoting apoptosis and autophagyWorld Journal of Gastrointestinal Oncology 2025; 17(6): 105570 doi: 10.4251/wjgo.v17.i6.105570
9
Pengtao Chen, Wei Gu, Xin Bing, Liangyou Wang, Yongran Cheng, Xukai Chen, Dinghu Zhang, Tianhui Chen. Using period analysis to timely provide serial data on long-term survival for liver cancer patients from ChinaFrontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1801386
10
Nguyen H. Tran, Scott A. Soefje, Nivedita Rangarajan, Purushotham Krishnappa, Tyler E. Wagner, Stephen J. Valerio, Rye Anderson, Jody C. Olson. Patient Characteristics, Treatment Patterns, and Outcomes in Unresectable Hepatocellular Carcinoma Treated with First-Line Systemic Therapy in the United StatesCancers 2025; 17(21) doi: 10.3390/cancers17213499
11
Victória Dogani Rodrigues, Cláudia Rucco Penteado Detregiachi, Manuela dos Santos Bueno, Luíza Santos de Argollo Haber, Rachel Gomes Eleutério, Eliana de Souza Bastos Mazuqueli Pereira, Virgínia Maria Cavallari Strozze Catharin, Lidiane Indiani, Vitor Cavallari Strozze Catharin, Sérgio Zabotto Dantas, Kátia Portero Sloan, Caio Sergio Galina Spilla, Lance Alan Sloan, Karina Quesada, Sandra Maria Barbalho, Lucas Fornari Laurindo. Imperatorin: A Furanocoumarin with Potential in Combating Cancer Development and Progression—A Comprehensive ReviewPharmaceuticals 2026; 19(3) doi: 10.3390/ph19030436